EUVIMEDEUVIMED entdecken
Open Access

Engineered bacteria detect tumor DNA

Robert M Cooper iD, Josephine A Wright iD, Jia Q Ng iD, Jarrad M Goyne, Nobumi Suzuki iD, Young K Lee iD, Mari Ichinose iD, Georgette Radford iD, Feargal J Ryan iD, Shalni Kumar, Elaine M Thomas iD, Laura Vrbanac iD und 4 weitere

Science · 11.08.2023 · 381 (6658) · 682-686

DOI: 10.1126/science.adf3974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 11.08.2023. Verfasst von Robert M Cooper und 15 weiteren Autor:innen. Beteiligte Einrichtung: Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA. Hauptthemen laut MEDLINE: Colorectal Neoplasms, DNA, Neoplasm, Acinetobacter, Cell-Free Nucleic Acids. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synthetic biology has developed sophisticated cellular biosensors to detect and respond to human disease. However, biosensors have not yet been engineered to detect specific extracellular DNA sequences and mutations. Here, we engineered naturally competent Acinetobacter baylyi to detect donor DNA from the genomes of colorectal cancer (CRC) cells, organoids, and tumors. We characterized the functionality of the biosensors in vitro with coculture assays and then validated them in vivo with sensor bacteria delivered to mice harboring colorectal tumors. We observed horizontal gene transfer from the tumor to the sensor bacteria in our mouse model of CRC. This cellular assay for targeted, CRISPR-discriminated horizontal gene transfer (CATCH) enables the biodetection of specific cell-free DNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsDNA, NeoplasmAcinetobacterCell-Free Nucleic AcidsBiosensing TechniquesAnimalsHumansMiceMutationBioengineering

Substanzen

DNA, NeoplasmCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Synthetic Biology Institute, University of California, San Diego, La Jolla, CA 92093, USA.
  • Precision Cancer Medicine Theme, South Australia Health and Medical Research Institute, Adelaide, SA 5000, Australia.
  • Adelaide Medical School, University of Adelaide, Adelaide, SA 5000, Australia.
  • Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA 5042, Australia.
  • Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
  • Molecular Biology Section, Division of Biological Sciences, University of California, San Diego, La Jolla, CA 92093, USA.

ORCID-Profile: Robert M Cooper, Josephine A Wright, Jia Q Ng, Nobumi Suzuki, Young K Lee, Mari Ichinose, Georgette Radford, Feargal J Ryan, Elaine M Thomas, Laura Vrbanac, Rob Knight, Susan L Woods, Daniel L Worthley, Jeff Hasty

Förderung

  • NCI NIH HHS

Zitieren

APA

Cooper, R. M., Wright, J. A., Ng, J. Q., Goyne, J. M., Suzuki, N., Lee, Y. K., Ichinose, M., Radford, G., Ryan, F. J., Kumar, S., Thomas, E. M., Vrbanac, L., Knight, R., Woods, S. L., Worthley, D. L., & Hasty, J. (2023). Engineered bacteria detect tumor DNA. Science, 381(6658), 682-686. https://doi.org/10.1126/science.adf3974

Vancouver

Cooper RM, Wright JA, Ng JQ, Goyne JM, Suzuki N, Lee YK, et al. Engineered bacteria detect tumor DNA. Science. 2023;381(6658):682-686. doi:10.1126/science.adf3974

BibTeX
@article{Cooper2023,
  author = {Cooper, Robert M and Wright, Josephine A and Ng, Jia Q and Goyne, Jarrad M and Suzuki, Nobumi and Lee, Young K and Ichinose, Mari and Radford, Georgette and Ryan, Feargal J and Kumar, Shalni and Thomas, Elaine M and Vrbanac, Laura and Knight, Rob and Woods, Susan L and Worthley, Daniel L and Hasty, Jeff},
  title = {Engineered bacteria detect tumor DNA},
  journal = {Science},
  year = {2023},
  volume = {381},
  number = {6658},
  pages = {682--686},
  doi = {10.1126/science.adf3974}
}
Kostenlos starten →